CO1686,在II期: Objective responses have been observed in heavily pretreated T790M+ patients who are resistant to erlotinib. Additionally, metastasis shrinkage has been observed at multiple organ sites, including both brain and liver metastases.
脑转移应该有一定效果,但有高血糖及低血糖的副作用需要注意。